Herein, we tested: (i) whether MSI2 in CAFs promotes NSCLC cell motility and metastasis; (ii) how CAFs regulate NSCLC cell aggressiveness, e.g., through the secretome or direct interaction; and (iii) what are key mediators that contribute to their aggressiveness. Here, MSI2 is linked to non-small cell lung carcinoma.